Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.

Ramirez AH, Shi Y, Schildcrout JS, Delaney JT, Xu H, Oetjens MT, Zuvich RL, Basford MA, Bowton E, Jiang M, Speltz P, Zink R, Cowan J, Pulley JM, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC
Pharmacogenomics. 2012 13 (4): 407-18

PMID: 22329724 · PMCID: PMC3361510 · DOI:10.2217/pgs.11.164

MeSH Terms (23)

Adult African Americans Aged Aged, 80 and over Anticoagulants Aryl Hydrocarbon Hydroxylases Calcium-Binding Proteins Cytochrome P-450 CYP2C9 Cytochrome P-450 Enzyme System Cytochrome P450 Family 4 Dose-Response Relationship, Drug Drug Administration Schedule Electronic Health Records European Continental Ancestry Group Female Humans Male Middle Aged Mixed Function Oxygenases Polymorphism, Single Nucleotide Substance-Related Disorders Vitamin K Epoxide Reductases Warfarin

Connections (5)

This publication is referenced by other Labnodes entities: